PROVECTUS PHARMATECH, INC.
Patent Owner
Stats
- 19 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 19 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 375 Total Citation Count
- Nov 02, 1998 Earliest Filing
- 15 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9839688 Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancerJun 24, 15Dec 12, 17[A61K, C12N, C07K]
9808524 Combination of local and systemic immunomodulative therapies for melanoma and liver cancerJun 24, 15Nov 07, 17[A61K, C12N, C07K]
9750807 Combination of local and systemic immunomodulative therapies for melanoma and liver cancerJun 24, 15Sep 05, 17[A61K, C12N, C07K]
9422260 Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenesJun 12, 13Aug 23, 16[A61K, C07D]
9273022 Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′, 4′, 5′7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (Rose Bengal) and related xanthenesJul 30, 14Mar 01, 16[C07D]
9107887 Combination of local and systemic immunomodulative therapies for enhanced treatment of cancerMar 09, 12Aug 18, 15[A61K, C07K]
8974363 Topical medicaments and methods for photodynamic treatment of diseaseNov 08, 07Mar 10, 15[A61K]
8530675 Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (rose bengal) and related xanthenesSep 17, 10Sep 10, 13[C07D]
8470296 Intracorporeal medicaments for high energy phototherapeutic treatment of diseaseMar 08, 07Jun 25, 13[A61K]
7863047 Intracorporeal medicaments for photodynamic treatment of diseaseApr 25, 08Jan 04, 11[A61K, G01N, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0290,309 Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of CancerAbandonedJun 24, 15Oct 15, 15[A61K]
8557298 Medicaments for chemotherapeutic treatment of diseaseExpiredDec 06, 07Oct 15, 13[A61K, A61P]
2011/0097,280 Intracorporeal Medicaments for Photodynamic Treatment of DiseaseAbandonedDec 30, 10Apr 28, 11[A61K, A61P]
2010/0076,246 Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of DiseaseAbandonedAug 19, 09Mar 25, 10[A61K, A61P, A61N]
7648695 Medicaments for chemotherapeutic treatment of diseaseExpiredJul 06, 01Jan 19, 10[A61K, G01N, A61M]
2008/0311,035 Diagnostic Agents For Positron Emission Imaging Using Radiolabeled Halogenated XanthenesAbandonedAug 19, 08Dec 18, 08[A61K]
2007/0078,076 Intracorporeal medicaments for high energy phototherapeutic treatment of diseaseAbandonedOct 02, 06Apr 05, 07[A61K, A61N]
2007/0010,575 Intracorporeal medicaments for photodynamic treatment of diseaseAbandonedSep 15, 06Jan 11, 07[A61K]
2006/0199,859 Topical medicaments and methods for photodynamic treatment of diseaseAbandonedMay 08, 06Sep 07, 06[A61K]
2005/0282,889 Intracorporeal medicaments for photodynamic treatment of diseaseAbandonedJul 22, 05Dec 22, 05[A61K]
2003/0133,940 Medicaments for chemotherapeutic treatment of diseaseAbandonedDec 30, 02Jul 17, 03[A61K]
2002/0001,567 Intracorporeal medicaments for high energy phototherapeutic treatment of diseaseAbandonedMar 26, 01Jan 03, 02[A61K, A61N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.